Business

PRTC's Karuna Files IPO Registration Statement

PRTC's Karuna Files IPO Registration Statement.

articlePuretech Health PlcApril 26, 20195/company/puretech-health-plc/news/prtcs-karuna-files-ipo-registration-statement
PRTC's Karuna Files IPO Registration Statement

About this update from Puretech Health Plc

[{"type":"text","content":"\n \nRNS Number : 1729X PureTech Health PLC 26 April 2019  \n\n26 April 2019\n \nTHIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OR IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.\n \nPureTech Health plc\n \nPureTech's Karuna Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering\n \nPureTech Health plc (LSE: PRTC), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, is pleased to note that its affiliate, Karuna Therapeutics, Inc. (\"Karuna\"), today announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the United States Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The announcement is being issued in accordance with Rule 135 under the U.S. Securities Act of 1933, as amended.\n \nThe full text of the announcement from Karuna is as follows:\n \nKaruna Therapeutics Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering\nBOSTON, April 26, 2019 - Karuna Therapeutics, Inc. today announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the \"SEC\") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions. \nThis press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (\"Securities Act\"). This announcement is being issued in accordance with Rule 135 under the Securities Act. \n \n\n \n\n \nThis announcement does not constitute, or form part of, any offer or invitation to sell, allot or issue, or any solicit...

More updates from Puretech Health Plc